StockTipsArenaBeta

BUY Aequs Limited — Sarita Pansari

BUYAequs Limited
Aequs share price target & all analyst calls

bySarita PansariHorizon: NA (inferred Swing (≤2wk))4 Nov 2026via CNBC Awaaz.

Entry₹217.81Inferred
Target₹225
Total upside +3.30% (call closed)
Stop loss₹203-6.80% risk
Exit₹2255 Nov 2026, 9:20 am
Target hit+3.30%0.00%upside left
Follow Sarita Pansari for new callsGet alertsWatch AEQUS for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 5 Nov 2026
1 supporting2 neutral3 opposing
Supports the BUY call (1)

Aequs Limited reported a 45% year-over-year revenue growth to INR 4,091 million for Q2, with first-half revenue rising 50%.

BSE · Company Update·26 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (2)

Aequs Ltd reported its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.

BSE · Board Meeting·26 Oct · 1w ago

(opens in new tab)

Aequs Limited reported unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.

NSE · Outcome of Board Meeting·26 Oct · 1w ago

(opens in new tab)
Weighs against the BUY call (3)

Aequs shares crash 19% after Q2 2026 losses widen; Buy, sell or hold? | Brokerage weighs in on what’s next

NewsLivemint·27 Oct · 1w ago

(opens in new tab)

Aequs shares plunge 18% after Q2 loss widens, consumer EBITDA breakeven timeline delayed

NewsCnbc-Tv18·27 Oct · 1w ago

(opens in new tab)

Aequs Q2 results: Loss widens to ₹52 crore despite 45% revenue growth

NewsCnbc-Tv18·26 Oct · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aequs

All analyst calls on Aequs

More from Sarita Pansari

Every call and its outcome